Literature DB >> 11236849

Neurotoxicity and neurocognitive impairments with alcohol and drug-use disorders: potential roles in addiction and recovery.

S C Bowden1, F T Crews, M E Bates, W Fals-Stewart, M L Ambrose.   

Abstract

This article represents the proceedings of a symposium at the 2000 RSA Meeting in Denver, Colorado. The organisers/chairs were Stephen C. Bowden and Fulton T. Crews. The presentations were (1) Age, genetic and other factors that increase risk of alcoholism also increase alcohol-induced neurotoxicity, by Fulton T. Crews; (2) A neurocognitive moderation model of addictions treatment response, by Marsha E. Bates; (3) The relationship of neurocognitive impairment and longitudinal treatment outcome among substance-abusing patients, by William Fals-Stewart; and (4) Treatment of cognition in detoxifying alcohol-dependent participants, by Margaret L. Ambrose.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11236849

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  17 in total

1.  A randomized controlled trial of cognitive remediation and work therapy in the early phase of substance use disorder recovery for older veterans: Neurocognitive and substance use outcomes.

Authors:  Morris D Bell; Holly B Laws; Ismene B Petrakis
Journal:  Psychiatr Rehabil J       Date:  2016-10-10

2.  Neural correlates of a Go/NoGo task with alcohol stimuli in light and heavy young drinkers.

Authors:  Susan L Ames; Savio W Wong; Antoine Bechara; Christopher Cappelli; Mark Dust; Jerry L Grenard; Alan W Stacy
Journal:  Behav Brain Res       Date:  2014-08-27       Impact factor: 3.332

Review 3.  Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.

Authors:  Luke A Downey; Jennifer M Loftis
Journal:  Eur J Pharmacol       Date:  2014-01-28       Impact factor: 4.432

Review 4.  New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders.

Authors:  Elias Dakwar; Edward V Nunes
Journal:  Curr Psychiatry Rep       Date:  2016-07       Impact factor: 5.285

5.  Rats selectively bred for ethanol preference or nonpreference have altered working memory.

Authors:  Galen R Wenger; Camron J Hall
Journal:  J Pharmacol Exp Ther       Date:  2010-02-22       Impact factor: 4.030

6.  Binge ethanol exposure induces endoplasmic reticulum stress in the brain of adult mice.

Authors:  Yongchao Wang; Xin Wang; Hui Li; Mei Xu; Jacqueline Frank; Jia Luo
Journal:  Toxicol Appl Pharmacol       Date:  2018-08-13       Impact factor: 4.219

7.  Repeated moderate-dose ethanol bouts impair cognitive function in Wistar rats.

Authors:  Alexander Kuzmin; Sture Liljequist; Jennifer Meis; Vladimir Chefer; Toni Shippenberg; Georgy Bakalkin
Journal:  Addict Biol       Date:  2011-10-26       Impact factor: 4.280

Review 8.  Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside.

Authors:  Steven M Graves; Roueen Rafeyan; Jeffrey Watts; T Celeste Napier
Journal:  Pharmacol Ther       Date:  2012-08-29       Impact factor: 12.310

9.  Effects of alcoholism severity and smoking on executive neurocognitive function.

Authors:  Jennifer M Glass; Anne Buu; Kenneth M Adams; Joel T Nigg; Leon I Puttler; Jennifer M Jester; Robert A Zucker
Journal:  Addiction       Date:  2009-01       Impact factor: 6.526

Review 10.  Current hypotheses on the mechanisms of alcoholism.

Authors:  R P Vetreno; F T Crews
Journal:  Handb Clin Neurol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.